Astiva Health announced that it has begun the process of registering shares on the Nasdaq Global Select for a drect listing.
The specific number of shares to be offered and the price range are yet to be determined, the company said in a press release. The offer is contingent upon market conditions, and there is no assurance regarding the completion, size, or terms.
Astiva is a Medicare Advantage Prescription Drug health plan.
Astiva plans to file privately via DRS this month.
Spartan Capital is the underwriter. The company is targeting a Q1 IPO, pending regulatory approval. Read more.
